Issue 6/2010
Content (17 Articles)
IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo
Tania Benatar, Ming Y. Cao, Yoon Lee, Jeff Lightfoot, Ningping Feng, Xiaoping Gu, Vivian Lee, Hongnan Jin, Ming Wang, Jim A. Wright, Aiping H. Young
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment
Thaís Helena Gasparoto, Tatiana Salles de Souza Malaspina, Luciana Benevides, Edgard Jose Franco de Melo Jr, Maria Renata Sales Nogueira Costa, José Humberto Damante, Maura Rosane Valério Ikoma, Gustavo Pompermaier Garlet, Karen Angélica Cavassani, João Santana da Silva, Ana Paula Campanelli
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked
Marie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, Sylvia Feyler, Sarah Jarmin, Ruth Morgan, Axel Glasmacher, Angela Märten, Ingo G. H. Schmidt-Wolf, Peter Brossart, Gordon Cook
Circulating tumour-derived microvesicles in plasma of gastric cancer patients
Jaroslaw Baran, Monika Baj-Krzyworzeka, Kazimierz Weglarczyk, Rafal Szatanek, Maria Zembala, Jakub Barbasz, Antoni Czupryna, Antoni Szczepanik, Marek Zembala
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting
Håkan Norell, Yi Zhang, James McCracken, Telma Martins da Palma, Aaron Lesher, Yueying Liu, Jeffrey J. Roszkowski, Anquanette Temple, Glenda G. Callender, Timothy Clay, Rimas Orentas, José Guevara-Patiño, Michael I. Nishimura
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
Adam Dangoor, Paul Lorigan, Ulrich Keilholz, Dirk Schadendorf, Adrian Harris, Christian Ottensmeier, John Smyth, Klaus Hoffmann, Richard Anderson, Martin Cripps, Joerg Schneider, Robert Hawkins
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity
Norimasa Matsushita, Hiroshi Komine, Annabelle Grolleau-Julius, Shari Pilon-Thomas, James J. Mulé
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity
Hong Lin, Elisa de Stanchina, Xi Kathy Zhou, Feng Hong, Andrew Seidman, Monica Fornier, Wei-Lie Xiao, Edward J. Kennelly, Kathleen Wesa, Barrie R. Cassileth, Susanna Cunningham-Rundles
Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice
Bohan Dong, Luguo Sun, Xiuli Wu, Peiyin Zhang, Li Wang, Hongfei Wei, Lei Zhou, Xiaoping Hu, Yongli Yu, Shucheng Hua, Liying Wang
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
Martin Pölcher, Michael Braun, Nicolaus Friedrichs, Christian Rudlowski, Eva Bercht, Rolf Fimmers, Axel Sauerwald, Mignon-Denise Keyver-Paik, Kirsten Kübler, Reinhard Büttner, Walther C. Kuhn, Juan-José Hernando
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells
Nadine Pouw, Elike Treffers-Westerlaken, Jaco Kraan, Floyd Wittink, Timo ten Hagen, Jaap Verweij, Reno Debets
Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro
Yinting Chen, Kaihong Huang, Xuexian Li, Xiangan Lin, Zhaohua Zhu, Ying Wu
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Brian M. Olson, Thomas P. Frye, Laura E. Johnson, Lawrence Fong, Keith L. Knutson, Mary L. Disis, Douglas G. McNeel
“Tumor immunology meets oncology IV”, 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany
Juergen Bukur, Dennis Loeffler, Chiara Massa, Lutz Mueller, Dagmar Riemann, Hans-Joachim Schmoll, Barbara Seliger
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008
Michele Maio, Hugues J. M. Nicolay, Paolo A. Ascierto, Filippo Belardelli, Roberto Camerini, Mario P. Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Ester Fonsatti, Giorgio Parmiani
The second cellular therapy of cancer symposium, 27–29 March 2009, Milan, Italy
John S. Bridgeman, David E. Gilham, Robert E. Hawkins, Eleanor J. Cheadle